Small molecule stimulators of neuronal growth
Provided herein are small molecule stimulators of neuronal growth, their preparation, and their use for treatment of neurological disorders. In one embodiment, provided herein are methods of treatment, prevention, or amelioration of a variety of medical conditions associated with neurological disorders using the compounds and compositions provided herein.
1. A method of modulating neuronal growth, said method comprising contacting a cell with an effective amount of a compound of the following formula:
or a pharmaceutically acceptable derivative thereof, wherein each of R1, R2, R3, and R4 are selected as follows:
(i) R1 is selected from sulfate, phosphate, and carboxylate; R2 is selected from sulfate, phosphate and carboxylate; and R3 and R4 are hydrogen;
(ii) R3 is selected from sulfate, phosphate, and carboxylate; R4 is selected from sulfate, phosphate, and carboxylate; and R1 and R2 are hydrogen;
(iii) R1 is selected from sulfate, phosphate, and carboxylate; R2 is selected from sulfate, phosphate, and carboxylate; R3 is selected from sulfate, phosphate, and carboxylate; and R4 is hydrogen;
(iv) R1 is selected from sulfate, phosphate, and carboxylate; R2 is selected from sulfate, phosphate, and carboxylate; R4 is selected from sulfate, phosphate, and carboxylate; and R3 is hydrogen;
(v) R2 is selected from sulfate, phosphate, and carboxylate; R4 is selected from sulfate, phosphate, and carboxylate; and R1 and R3 are hydrogen;
(vi) R1 is selected from sulfate, phosphate, and carboxylate; and R2, R3, and R4 are hydrogen;
(vii) R2 is selected from sulfate, phosphate, and carboxylate; and R1, R3, and R4 are hydrogen;
(viii) R3 is selected from sulfate, phosphate, and carboxylate; and R1, R2, and R4 are hydrogen; or
(ix) R4 is selected from sulfate, phosphate, and carboxylate; and R1, R2, and R3 are hydrogen;
with the provisos that (a) when R1 is sulfate, then R2 is other than H; (b) when R2 is sulfate then R1 is other than H; and R5 is selected from optionally substituted alkyl and optionally substituted alkenyl; and n is 0-100.
2. The method of claim 1 , wherein the method results in promotion of neurite outgrowth.
3. The method of claim 1 , wherein the method results in inhibition of neurite outgrowth.
4. The method of claim 1 , wherein the cell is from a neuronal tissue.
5. The method of claim 1 , wherein the cell is a cell from a brain, a central nervous system, or a peripheral nervous system.
6. The method of claim 1 , wherein the method results in inhibiting regeneration of an injured nerve.
7. The method of claim 1 , wherein the method results in promoting regeneration of an injured nerve.
8. The method of claim 7 , wherein the cultured neuronal cell is a hippocampal neuron, a dopaminergic neuron, or a dorsal root ganglion neuron.
9. A method of inducing growth of a differentiated neural stem cell comprising contacting a neural stem cell with an effective amount of a compound of the following formula:
or a pharmaceutically acceptable derivative thereof, wherein each of R1, R2, R3, and R4 are selected as follows:
(i) R1 is selected from sulfate, phosphate, and carboxylate; R2 is selected from sulfate, phosphate and carboxylate; and R3 and R4 are hydrogen;
(ii) R3 is selected from sulfate, phosphate, and carboxylate; R4 is selected from sulfate, phosphate, and carboxylate; and R1 and R2 are hydrogen;
(iii) R1 is selected from sulfate, phosphate, and carboxylate; R2 is selected from sulfate, phosphate, and carboxylate; R3 is selected from sulfate, phosphate, and carboxylate; and R4 is hydrogen;
(iv) R1 is selected from sulfate, phosphate, and carboxylate; R2 is selected from sulfate, phosphate, and carboxylate; R4 is selected from sulfate, phosphate, and carboxylate; and R3 is hydrogen;
(v) R2 is selected from sulfate, phosphate, and carboxylate; R4 is selected from sulfate, phosphate, and carboxylate; and R1 and R3 are hydrogen;
(vi) R1 is selected from sulfate, phosphate, and carboxylate; and R2, R3, and R4 are hydrogen;
(vii) R2 is selected from sulfate, phosphate, and carboxylate; and R1, R3, and R4 are hydrogen;
(viii) R3 is selected from sulfate, phosphate, and carboxylate; and R1, R2, and R4 are hydrogen; or
(ix) R4 is selected from sulfate, phosphate, and carboxylate; and R1, R2, and R3 are hydrogen;
with the provisos that (a) when R1 is sulfate, then R2 is other than H; (b) when R2 is sulfate then R1 is other than H; and R5 is selected from optionally substituted alkyl and optionally substituted alkenyl; and n is 0-100.
10. A method of treating a symptom associated with a neurodegenerative disorder or an injury of neural tissue comprising administering to a subject in need thereof an effective amount of a compound of the following formula:
or a pharmaceutically acceptable derivative thereof, wherein each of R1, R2, R3, and R4 are selected as follows:
(i) R1 is selected from sulfate, phosphate, and carboxylate; R2 is selected from sulfate, phosphate and carboxylate; and R3 and R4 are hydrogen;
(ii) R3 is selected from sulfate, phosphate, and carboxylate; R4 is selected from sulfate, phosphate, and carboxylate; and R1 and R2 are hydrogen;
(iii) R1 is selected from sulfate, phosphate, and carboxylate; R2 is selected from sulfate, phosphate, and carboxylate; R3 is selected from sulfate, phosphate, and carboxylate; and R4 is hydrogen;
(iv) R1 is selected from sulfate, phosphate, and carboxylate; R2 is selected from sulfate, phosphate, and carboxylate; R4 is selected from sulfate, phosphate, and carboxylate; and R3 is hydrogen;
(v) R2 is selected from sulfate, phosphate, and carboxylate; R4 is selected from sulfate, phosphate, and carboxylate; and R1 and R3 are hydrogen;
(vi) R1 is selected from sulfate, phosphate, and carboxylate; and R2, R3, and R4 are hydrogen;
(vii) R2 is selected from sulfate, phosphate, and carboxylate; and R1, R3, and R4 are hydrogen;
(viii) R3 is selected from sulfate, phosphate, and carboxylate; and R1, R2, and R4 are hydrogen; or
(ix) R4 is selected from sulfate, phosphate, and carboxylate; and R1, R2, and R3 are hydrogen;
with the provisos that (a) when R1 is sulfate, then R2 is other than H; (b) when R2 is sulfate then R1 is other than H; and R5 is selected from optionally substituted alkyl and optionally substituted alkenyl; and n is 0-100.
11. The method of claim 10 , wherein the disorder is a CNS lesion, gliosis, Parkinson's Disease, Alzheimer's Disease, or neuronal degeneration.
12. The method of claim 10 , wherein the disorder is spinal cord trauma.
13. A method of modulating the activity of a growth factor comprising contacting a cell with an effective amount a compound comprising:
or a pharmaceutically acceptable derivative thereof, wherein each of R1, R2, R3, and R4 are selected as follows:
(i) R1 is selected from sulfate, phosphate, and carboxylate; R2 is selected from sulfate, phosphate and carboxylate; and R3 and R4 are hydrogen;
(ii) R3 is selected from sulfate, phosphate, and carboxylate; R4 is selected from sulfate, phosphate, and carboxylate; and R1 and R2 are hydrogen;
(iii) R1 is selected from sulfate, phosphate, and carboxylate; R2 is selected from sulfate, phosphate, and carboxylate; R3 is selected from sulfate, phosphate, and carboxylate; and R4 is hydrogen;
(iv) R1 is selected from sulfate, phosphate, and carboxylate; R2 is selected from sulfate, phosphate, and carboxylate; R4 is selected from sulfate, phosphate, and carboxylate; and R3 is hydrogen;
(v) R2 is selected from sulfate, phosphate, and carboxylate; R4 is selected from sulfate, phosphate, and carboxylate; and R1 and R3 are hydrogen;
(vi) R1 is selected from sulfate, phosphate, and carboxylate; and R2, R3, and R4 are hydrogen;
(vii) R2 is selected from sulfate, phosphate, and carboxylate; and R1, R3, and R4 are hydrogen;
(viii) R3 is selected from sulfate, phosphate, and carboxylate; and R1, R2, and R4 are hydrogen; or
(ix) R4 is selected from sulfate, phosphate, and carboxylate; and R1, R2, and R3 are hydrogen;
with the provisos that (a) when R1 is sulfate, then R2 is other than H; (b) when R2 is sulfate then R1 is other than H; and R5 is selected from optionally substituted alkyl and optionally substituted alkenyl; and n is 0-100.
14. The method of claim 13 , wherein the growth factor is a nerve growth factor or fibroblast growth factor.